Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions

Tanja Kuhlmann, Claudia F Lucchinetti, Uwe K. Zettl, Andreas Bitsch, Hans Lassmann, Wolfgang Brück

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system leading to selective destruction of myelin sheaths and/or oligodendrocytes. The immunological mechanisms responsible for myelin destruction and the primary target of the immune response have not yet been identified. Prior studies have reported a variable degree of oligodendrocyte preservation in actively demyelinating lesions. We have previously demonstrated that oligodendrocyte survival is heterogenous and varies between individual MS patients. Bcl-2 belongs to the group of apoptosis-associated proteins that protects cells from cell death. The purpose of the present study was to determine whether bcl-2 expression is associated with oligodendrocyte preservation observed in some early MS lesions. Double immunocytochemistry was performed with antibodies against bcl-2 and myelin oligodendrocyte glycoprotein (MOG) to identify bcl-2-expressing oligodendrocytes within MS lesions from 43 patients. The number of bcl-2-positive oligodendrocytes was determined depending on the lesion demyelinating activity and the disease course of the patients. The number of bcl-2-expressing oligodendrocytes increased within demyelinating lesions compared to the periplaque white matter, with highest numbers in remyelinating lesions. There was a significant association between the presence of bcl-2-positive oligodendrocytes and the presence of remyelination. The highest proportion of bcl-2-positive oligodendrocytes was observed in a subgroup of patients with relapsing-remitting disease course. The expression of apoptosis-associated proteins may contribute to oligodendrocyte preservation or loss in MS lesions.

Original languageEnglish (US)
Pages (from-to)34-39
Number of pages6
JournalGLIA
Volume28
Issue number1
DOIs
StatePublished - 1999

Fingerprint

Oligodendroglia
Multiple Sclerosis
Myelin Sheath
Myelin-Oligodendrocyte Glycoprotein
Apoptosis
Demyelinating Diseases
Proteins
Chronic Disease
Cell Death
Central Nervous System
Immunohistochemistry
Antibodies

Keywords

  • Apoptosis
  • Bcl-2
  • Multiple sclerosis
  • Oligodendrocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. / Kuhlmann, Tanja; Lucchinetti, Claudia F; Zettl, Uwe K.; Bitsch, Andreas; Lassmann, Hans; Brück, Wolfgang.

In: GLIA, Vol. 28, No. 1, 1999, p. 34-39.

Research output: Contribution to journalArticle

Kuhlmann, Tanja ; Lucchinetti, Claudia F ; Zettl, Uwe K. ; Bitsch, Andreas ; Lassmann, Hans ; Brück, Wolfgang. / Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. In: GLIA. 1999 ; Vol. 28, No. 1. pp. 34-39.
@article{debe84731b844f30b58e02a5c7572b83,
title = "Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions",
abstract = "Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system leading to selective destruction of myelin sheaths and/or oligodendrocytes. The immunological mechanisms responsible for myelin destruction and the primary target of the immune response have not yet been identified. Prior studies have reported a variable degree of oligodendrocyte preservation in actively demyelinating lesions. We have previously demonstrated that oligodendrocyte survival is heterogenous and varies between individual MS patients. Bcl-2 belongs to the group of apoptosis-associated proteins that protects cells from cell death. The purpose of the present study was to determine whether bcl-2 expression is associated with oligodendrocyte preservation observed in some early MS lesions. Double immunocytochemistry was performed with antibodies against bcl-2 and myelin oligodendrocyte glycoprotein (MOG) to identify bcl-2-expressing oligodendrocytes within MS lesions from 43 patients. The number of bcl-2-positive oligodendrocytes was determined depending on the lesion demyelinating activity and the disease course of the patients. The number of bcl-2-expressing oligodendrocytes increased within demyelinating lesions compared to the periplaque white matter, with highest numbers in remyelinating lesions. There was a significant association between the presence of bcl-2-positive oligodendrocytes and the presence of remyelination. The highest proportion of bcl-2-positive oligodendrocytes was observed in a subgroup of patients with relapsing-remitting disease course. The expression of apoptosis-associated proteins may contribute to oligodendrocyte preservation or loss in MS lesions.",
keywords = "Apoptosis, Bcl-2, Multiple sclerosis, Oligodendrocytes",
author = "Tanja Kuhlmann and Lucchinetti, {Claudia F} and Zettl, {Uwe K.} and Andreas Bitsch and Hans Lassmann and Wolfgang Br{\"u}ck",
year = "1999",
doi = "10.1002/(SICI)1098-1136(199910)28:1<34::AID-GLIA4>3.0.CO;2-8",
language = "English (US)",
volume = "28",
pages = "34--39",
journal = "GLIA",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions

AU - Kuhlmann, Tanja

AU - Lucchinetti, Claudia F

AU - Zettl, Uwe K.

AU - Bitsch, Andreas

AU - Lassmann, Hans

AU - Brück, Wolfgang

PY - 1999

Y1 - 1999

N2 - Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system leading to selective destruction of myelin sheaths and/or oligodendrocytes. The immunological mechanisms responsible for myelin destruction and the primary target of the immune response have not yet been identified. Prior studies have reported a variable degree of oligodendrocyte preservation in actively demyelinating lesions. We have previously demonstrated that oligodendrocyte survival is heterogenous and varies between individual MS patients. Bcl-2 belongs to the group of apoptosis-associated proteins that protects cells from cell death. The purpose of the present study was to determine whether bcl-2 expression is associated with oligodendrocyte preservation observed in some early MS lesions. Double immunocytochemistry was performed with antibodies against bcl-2 and myelin oligodendrocyte glycoprotein (MOG) to identify bcl-2-expressing oligodendrocytes within MS lesions from 43 patients. The number of bcl-2-positive oligodendrocytes was determined depending on the lesion demyelinating activity and the disease course of the patients. The number of bcl-2-expressing oligodendrocytes increased within demyelinating lesions compared to the periplaque white matter, with highest numbers in remyelinating lesions. There was a significant association between the presence of bcl-2-positive oligodendrocytes and the presence of remyelination. The highest proportion of bcl-2-positive oligodendrocytes was observed in a subgroup of patients with relapsing-remitting disease course. The expression of apoptosis-associated proteins may contribute to oligodendrocyte preservation or loss in MS lesions.

AB - Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system leading to selective destruction of myelin sheaths and/or oligodendrocytes. The immunological mechanisms responsible for myelin destruction and the primary target of the immune response have not yet been identified. Prior studies have reported a variable degree of oligodendrocyte preservation in actively demyelinating lesions. We have previously demonstrated that oligodendrocyte survival is heterogenous and varies between individual MS patients. Bcl-2 belongs to the group of apoptosis-associated proteins that protects cells from cell death. The purpose of the present study was to determine whether bcl-2 expression is associated with oligodendrocyte preservation observed in some early MS lesions. Double immunocytochemistry was performed with antibodies against bcl-2 and myelin oligodendrocyte glycoprotein (MOG) to identify bcl-2-expressing oligodendrocytes within MS lesions from 43 patients. The number of bcl-2-positive oligodendrocytes was determined depending on the lesion demyelinating activity and the disease course of the patients. The number of bcl-2-expressing oligodendrocytes increased within demyelinating lesions compared to the periplaque white matter, with highest numbers in remyelinating lesions. There was a significant association between the presence of bcl-2-positive oligodendrocytes and the presence of remyelination. The highest proportion of bcl-2-positive oligodendrocytes was observed in a subgroup of patients with relapsing-remitting disease course. The expression of apoptosis-associated proteins may contribute to oligodendrocyte preservation or loss in MS lesions.

KW - Apoptosis

KW - Bcl-2

KW - Multiple sclerosis

KW - Oligodendrocytes

UR - http://www.scopus.com/inward/record.url?scp=0033215505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033215505&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1136(199910)28:1<34::AID-GLIA4>3.0.CO;2-8

DO - 10.1002/(SICI)1098-1136(199910)28:1<34::AID-GLIA4>3.0.CO;2-8

M3 - Article

VL - 28

SP - 34

EP - 39

JO - GLIA

JF - GLIA

SN - 0894-1491

IS - 1

ER -